|The secret behind VelaShape is that it is the first and only technology that combines elōs with vacuum and tissue manipulation to reduce the volume and appearance of fat tissues.|
The unique elōs combination of light and bi-polar radio frequency (RF) energies and negative pressure deploy targeted heat to adipose tissue. Bi-polar radio frequency, infrared light, tissue mobilization, and suction, all work synergistically to reduce the appearance of cellulite and facilitate new collagen deposition. The net result increases lipolysis, which shrinks the size of the fat chamber. Shrinkage of the fat chamber reduces the dimpling of the skin, which supports improvements in the hypodermis.
Gradual improvement of the treated area can be seen following the first treatment — with the skin surface of the treated area feeling smoother and firmer.
Pulsed, Focused Ultrasound with UltraShape Technology
The UltraShape V3 works by emitting acoustic waves of ultrasonic energy that converge into a confined focal volume targeting only subcutaneous fat at a controlled depth. Unlike traditional ultrasound technology, UltraShape V3’s energy transmits pulsed ultrasound, allowing control over temperature elevation (less than 0.5o C increase) and enabling fat destruction to occur instantly, selectively and mechanically (non-thermal). is the latest non-invasive alternative that’s clinically proven to reduce localized fat deposits and body circumference to meet the needs of your patients.
VDF™ Single-Focus Ultrasound
VDF™ Multi-Focus Ultrasound
Immediate, Selective Fat Cell Destruction
Histology confirms UltraShape technology instantly and selectively destroys fat cells alone¹.
Natural Fat Clearance2
The UltraShape procedure is based on a natural fat clearance process where triglycerides and cell debris from the immediately destroyed fat cells are processed by the body’s natural physiological and metabolic pathways. These pathways are the same that handle fat during weight loss. Results from UltraShape’s peer-reviewed published multi-center controlled clinical trial and other independent clinical studies show that the released triglycerides do not accumulate to a clinically significant extent in the blood or liver.3